Advertisement
News
Subscribe to MDT Magazine News

Mersana moves anti-cancer drug target along in trials

March 25, 2011 11:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Mersana Therapeutics Inc., a Cambridge cancer therapeutics developer, has begun a Phase 1b extension study of its treatment for second-line gastric cancer and second- and third-line non-small cell lung cancer.

TOPICS:

AACR honors eminent researchers

March 25, 2011 11:33 am | by EurekAlert | Comments

(American Association for Cancer Research) The American Association for Cancer Research will recognize leading cancer researchers whose work has significantly contributed to progress in the fight against cancer at the AACR 102nd Annual Meeting 2011. Each recipient will present an...

TOPICS:

Medtronic gets approval for heart products

March 25, 2011 10:45 am | by The Associated Press | Comments

Medical device maker Medtronic Inc. said Friday it received Food & Drug Administration for two heart pacemaker systems.The company said it received approval for its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems. It said Consulta is the first cardiac resynchronization...

Advertisement

BG Medicine lands heart test deal

March 25, 2011 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

BG Medicine Inc., a Waltham developer of cardiac diagnostics, has teamed with Health Diagnostic Laboratory Inc. in a deal in which BG's Galectin-3 test will complement HDL's testing services for the galectin-3 protein.

BU names two new life sciences-focused biz dev execs

March 25, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

The Boston University Office of Technology Development has picked Nelson Medeiros for the new role of Director of Business Development for Medical Devices and Instrumentation and Elizabeth Carlson as Licensing Director for Life Sciences.

FDA Approves New Treatment for a Type of Late-Stage Skin Cancer

March 25, 2011 9:36 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 25, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO...

TOPICS:

New Interim Data About Combination Oral Contraceptives

March 25, 2011 9:36 am | by Bio-Medicine.Org | Comments

WAYNE, N.J., March 25, 2011 /- Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk...

TOPICS:

CoreLab Partners Collaborates at Worldwide Industry Conferences

March 25, 2011 9:35 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., March 25, 2011 /- CoreLab Partners, Inc , the global entity resulting from the merger between RadPharm, Inc and Medifacts International, is set to attend and actively participate in several upcoming industry events around the world over the next two weeks. "The legacy of...

TOPICS:
Advertisement

Med Ad News Magazine Announces Nominees for the 22nd Annual Manny Awards as Well as Advertising Person of the Year

March 25, 2011 9:35 am | by Bio-Medicine.Org | Comments

NEWTOWN, Pa., March 25, 2011 /- Today, Med Ad News announces the nominees for the 22nd Annual Manny Awards and the Advertising Person of the Year. The awards ceremony will be held on Thursday, April 28, 2011, at the Sheraton New York Hotel and Towers in New York, N.Y. The Manny Awards is...

TOPICS:

High Quality Above All Else in Your Practice, Part 1 of 2

March 25, 2011 9:34 am | by Diagnostic Imaging | Comments

We've considered how the competitive nature of the marketplace has influenced practice behavior, or should. Chiefly, what sets you apart? That is, what value do you add? And how do you make sure your practice is of high quality?

TOPICS:

The German National Academy of Sciences Leopoldina sets up new standing committees

March 25, 2011 8:40 am | by EurekAlert | Comments

(Leopoldina) The German National Academy of Sciences Leopoldina has set up seven new standing committees in order to be able to work more intensively on topics of the future.

TOPICS:

Susan Band Horwitz, Ph.D., receives Eighth Annual AACR Award for Lifetime Achievement in Cancer Research

March 25, 2011 8:40 am | by EurekAlert | Comments

(American Association for Cancer Research) Susan Band Horwitz, Ph.D., will receive the Eighth Annual AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted pioneering research by discovering the mechanism of action of the chemotherapeutic drug paclitaxel (Taxol),...

TOPICS:

Researchers model cell behavior in live mice

March 25, 2011 8:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Researchers from MIT and Massachusetts General Hospital say they have created a computational model that helps to predict cell behavior inside a living animal.

Accretive Health stockholders selling 6.5M shares

March 25, 2011 7:45 am | by The Associated Press | Comments

Accretive Health Inc. said Friday that some of its shareholders are offering to sell 6.5 million shares of its stock for $23.50 per share, a 3 percent discount to their most recent closing price.Accretive Health, which went public last May, helps hospital systems manage their revenue cycles....

Utah Moves to License Radiologist Assistants

March 25, 2011 7:32 am | by Diagnostic Imaging | Comments

The national march toward regulating radiology extenders continues with Utah becoming the 29th state to regulate, license, or recognize radiologist assistants (RA) as part of the team.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading